Recent Finacing
Recent Raise
Genoskin develops live ex vivo human skin platforms that serve as ethical, scalable alternatives to animal testing for evaluating injected drugs, topical therapeutics and implanted medical devices.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Genoskin.